n.a. (BRLI)

34.61
0.34 0.97
NASDAQ
Prev Close 34.95
Open 34.74
Day Low/High 34.03 / 34.96
52 Wk Low/High /
Volume 423.74K
Exchange NASDAQ
Div & Yield N.A. (N.A)
5 Stocks Setting Up to Break Out

5 Stocks Setting Up to Break Out

These stocks look poised to break out and trade higher from current levels.

Bio-Reference Stock Hits New 52-Week High (BRLI)

Bio-Reference Stock Hits New 52-Week High (BRLI)

Bio-Reference Labs (Nasdaq:BRLI) hit a new 52-week high Thursday as it is currently trading at $24.49, above its previous 52-week high of $24.48 with 234,207 shares traded as of 4 p.m. ET. Average volume has been 223,400 shares over the past 30 days.

Look Up Bio-Reference

This health care company has a lot going for it from a fundamental and technical perspective.

Bio-Reference Laboratories, Inc. Reports Strong Quarterly Results

Bio-Reference Laboratories, Inc. Reports Strong Quarterly Results

(Numbers in thousands except per share data or where otherwise noted.

5 Stocks That Could Pop Post-Earnings

5 Stocks That Could Pop Post-Earnings

Heavy short interest could move to cover, fueling a price climb.

BioReference Laboratories, Inc. Announces Earnings Date For Second Quarter Fiscal Year 2012

BioReference Laboratories, Inc. Announces Earnings Date For Second Quarter Fiscal Year 2012

Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announced today it plans to issue earnings results for the second quarter of Fiscal 2012 before the open of market trading on Thursday, June 7, 2012.

Jarden, Bio-Reference Labs: Time to Buy?

Jarden, Bio-Reference Labs: Time to Buy?

Dan Veru, portfolio manager for the Pyxis Small-Cap Equity Fund, names his favorite stocks including Bio-Reference Labs, Oil States and Jarden.

10 Small-Cap Stocks Poised to Rise, History Shows (Update2)

10 Small-Cap Stocks Poised to Rise, History Shows (Update2)

Shares of smaller companies tend to rebound from big declines, S&P Capital IQ says.

Bio-Reference Laboratories, Inc. Announces Record First Quarter Revenue, Earnings And Cash Flow From Operations

Bio-Reference Laboratories, Inc. Announces Record First Quarter Revenue, Earnings And Cash Flow From Operations

(except for per share data or where otherwise noted, numbers are in thousands) Bio-Reference Laboratories, Inc.

Bio-Reference Laboratories, Inc. Announces Earnings Date For First Quarter Fiscal Year 2012

Bio-Reference Laboratories, Inc. Announces Earnings Date For First Quarter Fiscal Year 2012

Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announced today it plans to issue earnings results for the first quarter of Fiscal 2012 before the open of market trading on Thursday, March 1, 2012.

Look to Small-Caps for Big Winners

MWI Veterinary Supply, Bio-Reference Laboratories and Rue21 get high marks from two of my guru strategies.

BioReference Announces 2012 Annual Meeting Date

BioReference Announces 2012 Annual Meeting Date

Bio-Reference Laboratories, Inc. (“BioReference”) (NASDAQ: BRLI) announced today that it will hold its 2012 annual meeting of stockholders (the “Annual Meeting”) on July 12, 2012.

Bio-Reference Labs Inc. Stock Upgraded (BRLI)

Bio-Reference Labs Inc. Stock Upgraded (BRLI)

Bio-Reference Labs (Nasdaq:BRLI) has been upgraded by TheStreet Ratings from a hold to buy.

BioReference To Launch Groundbreaking Solid Tumor Genotyping Test Through Its GenPath Oncology Laboratory

BioReference To Launch Groundbreaking Solid Tumor Genotyping Test Through Its GenPath Oncology Laboratory

BioReference Laboratories, Inc. (NASDAQ: BRLI) and its GenPath Oncology business unit and through its exclusive commercialization agreement with the Massachusetts General Hospital (MGH) is introducing its ...

BioReference Laboratories, Inc. Announces Contract With Corizon, Inc. To Provide Correctional Healthcare Laboratory Services

BioReference Laboratories, Inc. Announces Contract With Corizon, Inc. To Provide Correctional Healthcare Laboratory Services

Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announced that effective January 1, 2012, it has entered into a new Master Agreement to provide diagnostic laboratory services for some of the facilities that Corizon, ...

Bio-Reference Laboratories, Inc. Announces Record Revenues, Earnings And Cash Flow For Fourth Quarter And Full Fiscal Year

Bio-Reference Laboratories, Inc. Announces Record Revenues, Earnings And Cash Flow For Fourth Quarter And Full Fiscal Year

(except for per share data or where otherwise noted, numbers are in thousands) Bio-Reference Laboratories, Inc.

BioReference Laboratories, Inc. Announces Earnings Date For Fourth Quarter And Year End For Fiscal Year 2011

BioReference Laboratories, Inc. Announces Earnings Date For Fourth Quarter And Year End For Fiscal Year 2011

Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announced today it plans to issue earnings results for the fourth quarter and fiscal year 2011 before the open of market trading on Thursday, December 8 th, 2011.

BioReference Laboratories, Inc. To Speak At The Oppenheimer 22nd Annual Healthcare Conference

BioReference Laboratories, Inc. To Speak At The Oppenheimer 22nd Annual Healthcare Conference

Bio-Reference Laboratories, Inc. (NASDAQ-“BRLI”) announced today that Marc D.

Bio-Reference Labs Inc. Stock Downgraded (BRLI)

Bio-Reference Labs Inc. Stock Downgraded (BRLI)

Bio-Reference Labs (Nasdaq:BRLI) has been downgraded by TheStreet Ratings from from a buy to hold.

Bio-Reference Laboratories, Inc. And McKesson Specialty Health’s Onmark GPO Execute Purchasing Agreement

Bio-Reference Laboratories, Inc. And McKesson Specialty Health’s Onmark GPO Execute Purchasing Agreement

Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announced today that it has entered into a purchasing agreement with a McKesson Specialty Health group purchasing organization (GPO), the Onmark GPO.

Bio-Reference Laboratories Named 8th Fastest Growing Company In State Of New Jersey

Bio-Reference Laboratories Named 8th Fastest Growing Company In State Of New Jersey

Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announced today that it has been named the 8 th Fastest Growing Company in New Jersey according to NJBiz at the 2011 50 Fastest Growing Companies of NJ award ceremony...

Bio-Reference Laboratories, Inc. Announces Stock Buy-Back Plan

Bio-Reference Laboratories, Inc. Announces Stock Buy-Back Plan

Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announced today that its board of directors has approved a Stock Repurchase Program authorizing the repurchase of up to 1,000,000 shares of its Common Stock in the ...

BioReference Laboratories, Inc To Speak At The Lazard Capital Markets 8th Annual Healthcare Conference

BioReference Laboratories, Inc To Speak At The Lazard Capital Markets 8th Annual Healthcare Conference

Bio-Reference Laboratories, Inc (NASDAQ-“BRLI”) announced today that Marc D.

Bio-Reference Rises On Unusually High Volume (BRLI)

Bio-Reference Rises On Unusually High Volume (BRLI)

Bio-Reference Labs (Nasdaq:BRLI) is trading at unusually high volume Tuesday with 1.2 million shares changing hands. It is currently at 4.1 times its average daily volume and trading up 85 cents (+5.3%).

GenPath Women’s Health In Collaboration With GeneDX To Launch Breakthrough In Genetic Screening For Family Planning

GenPath Women’s Health In Collaboration With GeneDX To Launch Breakthrough In Genetic Screening For Family Planning

At the National Society of Genetic Counselors meeting in San Diego, CA today, GenPath Women’s Health, one of the leading Women’s Health laboratories in the United States in collaboration with GeneDX, one of ...

GeneDx Unveils Groundbreaking Test To Identify Rare Inherited Diseases

GeneDx Unveils Groundbreaking Test To Identify Rare Inherited Diseases

At the joint conference of the American Society of Human Genetics/International Congress on Human Genetics in Montreal on October 12, GeneDx, one of the foremost genetics laboratories in the world and a subsidiary of...

BioReference Laboratories, Inc To Speak At The UBS Global Life Sciences Conference

BioReference Laboratories, Inc To Speak At The UBS Global Life Sciences Conference

BioReference Laboratories, Inc (NASDAQ-“BRLI”) announced today that Marc D.

Bio-Reference Laboratories, Inc. Reports 26% Increase In Net Income, 22% Increase In Net Revenue, 20% Increase In Patient Count

Bio-Reference Laboratories, Inc. Reports 26% Increase In Net Income, 22% Increase In Net Revenue, 20% Increase In Patient Count

Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) (Except for Per Share Data or where otherwise noted, numbers are in thousands) announced that the Company recorded current quarter revenues of $148,029, the best ever ...

5 Earnings Short-Squeeze Plays

5 Earnings Short-Squeeze Plays

As positive earnings come out and the bears rush to cover their positions, these stocks are poised pop.